• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用可生物降解微粒进行口服免疫后唾液、肠道、阴道和鼻腔的抗体反应。

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

作者信息

Challacombe S J, Rahman D, O'Hagan D T

机构信息

Department of Oral Medicine and Pathology, UMDS, Guy's Hospital, London, UK.

出版信息

Vaccine. 1997 Feb;15(2):169-75. doi: 10.1016/s0264-410x(96)00159-4.

DOI:10.1016/s0264-410x(96)00159-4
PMID:9066034
Abstract

The aims of this study were to determine whether oral immunization with microparticles might lead to a common mucosal response including vaginal secretions. Female Balb/c mice were immunized orally with microparticles containing ovalbumin at 0 and 4 weeks or with soluble antigen. Antibody responses were assayed by ELISA in saliva, gut washings, vaginal washings and serum, and antibody producing cells were assayed by ELISPOT in salivary glands and nasal cavity. After primary immunization, IgA antibodies were detected in vaginal washings, saliva and in gut washings which were significantly greater than those detected with soluble antigen (P < 0.01). After secondary immunization, greatly enhanced antibody titres were found in three fluids. The specific activity (antibody per microgram IgA) of antibodies in vaginal fluid and saliva was significantly greater than in serum or gut wash (P < 0.01). Oral immunization also resulted in the development of antibody forming cells in salivary glands and in nasal associated mucosal tissue. Immunization with microparticles containing antigen should prove useful in immunization against infections affecting a number of different mucosal surfaces.

摘要

本研究的目的是确定用微粒进行口服免疫是否会引发包括阴道分泌物在内的共同黏膜反应。雌性Balb/c小鼠在0周和4周时用含卵清蛋白的微粒进行口服免疫,或用可溶性抗原进行免疫。通过ELISA检测唾液、肠道灌洗液、阴道灌洗液和血清中的抗体反应,通过ELISPOT检测唾液腺和鼻腔中的抗体产生细胞。初次免疫后,在阴道灌洗液、唾液和肠道灌洗液中检测到IgA抗体,其含量显著高于用可溶性抗原检测到的抗体(P < 0.01)。二次免疫后,在三种液体中发现抗体滴度大大提高。阴道液和唾液中抗体的比活性(每微克IgA的抗体量)显著高于血清或肠道灌洗液(P < 0.01)。口服免疫还导致唾液腺和鼻相关黏膜组织中抗体形成细胞的发育。用含抗原的微粒进行免疫应证明对针对影响多个不同黏膜表面的感染进行免疫是有用的。

相似文献

1
Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.用可生物降解微粒进行口服免疫后唾液、肠道、阴道和鼻腔的抗体反应。
Vaccine. 1997 Feb;15(2):169-75. doi: 10.1016/s0264-410x(96)00159-4.
2
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.鼻腔、直肠或阴道免疫后女性黏膜和全身抗体反应的差异诱导:月经周期的影响
J Immunol. 2002 Jul 1;169(1):566-74. doi: 10.4049/jimmunol.169.1.566.
3
HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.艾滋病病毒黏膜疫苗:用包裹了gp160的日本血凝病毒-脂质体进行鼻腔免疫可诱导抗原特异性细胞毒性T淋巴细胞及中和抗体反应。
J Immunol. 2003 Jan 1;170(1):495-502. doi: 10.4049/jimmunol.170.1.495.
4
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.用含抗原的可生物降解微粒进行口服免疫后,分泌型IgA和全身性IgG抗体反应增强。
Immunology. 1992 May;76(1):164-8.
5
Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.对生殖器官和肠道相关淋巴组织进行免疫接种后,阴道分泌物、血清和唾液中IgA和IgG抗体的诱导情况。
Adv Exp Med Biol. 1995;371B:1567-73.
6
Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles.口服抗原与生物黏附性可降解淀粉微粒后诱导分泌性和血清抗体反应。
Oral Microbiol Immunol. 1998 Jun;13(3):139-49. doi: 10.1111/j.1399-302x.1998.tb00725.x.
7
Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.不同黏膜效应部位的抗体免疫反应之间的相关性受抗原类型和剂量的控制。
Infect Immun. 2000 Jul;68(7):3830-9. doi: 10.1128/IAI.68.7.3830-3839.2000.
8
Phycocyanin enhances secretary IgA antibody response and suppresses allergic IgE antibody response in mice immunized with antigen-entrapped biodegradable microparticles.藻蓝蛋白可增强用包裹抗原的可生物降解微粒免疫的小鼠的分泌型IgA抗体反应,并抑制其过敏性IgE抗体反应。
J Nutr Sci Vitaminol (Tokyo). 2004 Apr;50(2):129-36. doi: 10.3177/jnsv.50.129.
9
Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.衰老过程中的保护性黏膜免疫与鼻咽相关淋巴组织中功能性CD4+ T细胞有关。
J Immunol. 2003 Feb 15;170(4):1754-62. doi: 10.4049/jimmunol.170.4.1754.
10
Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.通过口服外膜蛋白免疫增强不可分型流感嗜血杆菌的鼻腔清除能力。
Acta Otolaryngol. 1998 Nov;118(6):864-9. doi: 10.1080/00016489850182594.

引用本文的文献

1
Demystifying particle-based oral vaccines.解析基于粒子的口服疫苗。
Expert Opin Drug Deliv. 2021 Oct;18(10):1455-1472. doi: 10.1080/17425247.2021.1946511. Epub 2021 Jul 6.
2
Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.用抗原偶联纳米颗粒进行经口免疫,随后进行皮下加强免疫,可在小鼠体内诱导持久的黏膜和全身抗体反应。
PLoS One. 2015 Feb 24;10(2):e0118067. doi: 10.1371/journal.pone.0118067. eCollection 2015.
3
Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity.
聚合物载体在小鼠生殖道内的疫苗传递可诱导持续的局部和全身免疫。
Mol Pharm. 2010 Oct 4;7(5):1585-95. doi: 10.1021/mp100009e. Epub 2010 Aug 26.
4
Application of nanotechnologies for improved immune response against infectious diseases in the developing world.纳米技术在提高发展中国家抗感染免疫反应中的应用。
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):378-93. doi: 10.1016/j.addr.2009.11.011. Epub 2009 Nov 14.
5
Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.一种稳定表达结核分枝杆菌Ag85B-ESAT6融合蛋白的活沙门氏菌疫苗的特性分析。
Vaccine. 2009 Nov 16;27(49):6894-904. doi: 10.1016/j.vaccine.2009.09.007. Epub 2009 Sep 13.
6
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.经口服给药途径后,纳米乳剂包封的MAGE1-HSP70/SEA复合蛋白疫苗诱导的抗肿瘤免疫反应。
Cancer Immunol Immunother. 2009 Feb;58(2):201-8. doi: 10.1007/s00262-008-0539-9. Epub 2008 Jun 4.
7
Past, present, and future technologies for oral delivery of therapeutic proteins.用于治疗性蛋白质口服递送的过去、现在和未来技术。
J Pharm Sci. 2008 Jul;97(7):2497-523. doi: 10.1002/jps.21183.
8
Mucosal immunity: overcoming the barrier for induction of proximal responses.黏膜免疫:克服诱导近端反应的障碍。
Immunol Res. 2004;30(1):35-71. doi: 10.1385/IR:30:1:035.
9
Recent advances in vaccine adjuvants.疫苗佐剂的最新进展。
Pharm Res. 2002 Jun;19(6):715-28. doi: 10.1023/a:1016104910582.
10
Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.来自磺丁基化聚乙烯醇接枝聚丙交酯-乙交酯共聚物的破伤风类毒素负载纳米颗粒:小鼠口服和鼻腔给药后抗体反应的评估
Pharm Res. 2001 Mar;18(3):352-60. doi: 10.1023/a:1011063232257.